- 1Institute of International Business & Economics Innovation and Governance, Shanghai University of International Business and Economics, Shanghai, China
- 2International Business School, Shanghai University of International Business and Economics, Shanghai, China
- 3CEEC Economic and Trade Cooperation Institute, Ningbo University, Ningbo, China
- 4College of Business Administration, Ningbo University of Finance and Economics, Ningbo, China
- 5School of Management, Zhejiang Gongshang University Hangzhou College of Commerce, Hangzhou, China
- 6Institute of Digital Economy and Financial Powerhouse Building, Guangdong University of Finance, Guangzhou, China
- 7Graduate School, Nueva Ecija University of Science and Technology, Cabanatuan, Philippines
- 8School of Economics and Management, Zhejiang Normal University, Jinhua, China
- 9School of Economics, Shanghai University, Shanghai, China
This study investigates the spatial structure and influencing factors of the innovation network in the advanced medical equipment and device manufacturing industry in the Yangtze River Delta (YRD). This industry is crucial to public health system resilience and regional industrial upgrading. Drawing on joint patent data from the IncoPat Global Patent Database covering the period 2005–2024, the study constructs innovation networks and conducts comparative analyses from both national and regional perspectives using social network analysis and geodetector methods. The findings reveal that: (1) At the national level, the innovation network has gradually expanded but remains sparse, characterized by a “core–periphery” structure dominated by Beijing and Shanghai. Urban participation in central and western China is limited. Short-term objectives often drive industry–university–research collaborations, and collaborations in basic research among academic institutions remain insufficient. (2) In contrast, the YRD region has formed a denser, polycentric network, with Shanghai as the primary hub and Nanjing and Suzhou as key secondary centers. Local enterprises exhibit strong incentives to engage in collaborative innovation within industry–university–research frameworks. (3) Geodetector analyses indicate that economic development, technological capability, and government policy support are major drivers of network formation, while infrastructure quality plays a crucial enabling role. The relative importance of these factors varies between national and regional levels. These results provide empirical evidence to inform regional innovation strategies and targeted policy design for strengthening collaboration in the advanced medical equipment industry.
1 Introduction
The advanced medical equipment and device manufacturing industry is a strategic emerging industry in China. Its development meets the growing demand for high-quality medical services and drives the transformation and upgrading of the national economy while improving China’s technological capabilities and innovation capacity in the medical sector (1–5). In 2023, the total revenue of China’s medical device industry reached 1.31 trillion yuan with a compound annual growth rate of 10%, making it the second-largest market globally.1 However, more than 80% of advanced medical equipment, such as radiotherapy equipment and MRI machines, continues to rely on imports.2 The Yangtze River Delta (YRD), which is endowed with abundant innovation resources and a highly skilled talent pool, emphasizes the development of advanced medical equipment and device manufacturing. As a core agglomeration area for China’s medical device industry, the YRD hosts more than 20% of the nation’s clinical and animal testing institutions for medical devices, with universities that offer medical device-related programs leading the country.3 Additionally, the region pioneered the Medical Device Marketing Authorization Holder system, which lays a solid foundation for the high-quality, integrated development of the industry.
Innovation serves as a crucial driver of high-quality regional economic development. The COVID-19 pandemic highlighted the vulnerabilities in global medical supply chains and emphasized the need for domestically driven innovation and production capacity. In this context, developing a resilient and localized medical innovation ecosystem is crucial for addressing future public health crises. The flow of innovation elements among cities that form innovation networks has drawn considerable attention from scholars and has become a central theme in research on innovation geography (6–10). In constructing innovation networks, studies have utilized data sources such as patent collaborations, transfers, citations, academic paper coauthorships, research project collaborations, and high-end talent mobility. These studies have applied social network analysis (SNA) methods to examine innovation networks (11–15). Early research primarily adopted a micro-level perspective, focusing on innovation actors such as enterprises, research institutions, and government organizations, and examined the structure of innovation networks as well as the interactions among these entities (16–22). As research has deepened, particularly in the knowledge economy era with the relational turn in economic geography and the widespread influence of network science, scholars have increasingly shifted to macro-level studies that investigate innovation networks at the national, urban cluster, and provincial levels. This shift has placed greater emphasis on the structural characteristics, influencing factors, and evolutionary processes of innovation networks (23–32). For instance, Feng Hu et al. identified a global scale-free innovation network centered around Europe and North America using cooperative patent data (33), while Yang et al. examined collaborative innovation in China’s telecommunications sector through negative binomial regression (34). Other researchers have analyzed innovation networks in regional contexts such as Anhui Province or across national urban systems. These studies confirm the importance of network centrality, connection strength, and knowledge flow efficiency in shaping innovation outcomes (35–38).
However, relatively few studies have specifically examined the advanced medical equipment industry in the Yangtze River Delta (YRD)—a key cluster region of China’s advanced manufacturing and public health technology innovation. Zhang and Rao conducted a macro-level SWOT–ANP analysis of China’s advanced medical equipment industry, highlighting systemic challenges such as weak enterprise R&D capabilities and fragmented university–industry cooperation (39). While their study offers important strategic insights, it lacks a spatial-network perspective and does not focus on regional collaboration patterns. Similarly, Lai et al. evaluated the innovation efficiency of the pharmaceutical manufacturing industry from a technology gap perspective, revealing regional disparities but without addressing inter-organizational innovation networks or patent-based collaboration structures (40).
Existing literature tends to focus on policy strategy, industrial risk, or innovation efficiency measurement at a provincial level, but seldom integrates relational data (e.g., joint patent applications) to analyze how innovation actors connect and form networks within a region. The present study addresses this gap by constructing a dynamic innovation network for the advanced medical equipment industry in the YRD, using longitudinal patent co-application data and comparative analysis across national and regional scales. This approach enables us to uncover how economic, technological, and institutional factors jointly shape collaborative structures in the advanced medical equipment and device manufacturing industry.
However, current cross-scale urban innovation network studies suffer from methodological limitations and cognitive gaps, and a shift beyond single spatial dimensions is required. The integration of the “global–local” (glocalization) paradigm is necessary to analyze the complex spatial characteristics of innovation cooperation (41–47). Furthermore, previous studies have focused primarily on innovation networks at the urban level with limited attention to heterogeneous characteristics across specific industries. Previous studies also lack sufficient consideration of how industry attributes influence network structures.
From an industrial perspective, studies of the advanced medical equipment and device manufacturing industry have focused mainly on its industrial development (2, 48–51), spatial distribution (5, 52, 53), trade patterns, and competitiveness (54–57). While these studies have provided in-depth analyses of the spatial–temporal characteristics of the industry, they often overlook relational perspectives. There is an urgent need to integrate network embeddedness effects and endogenous-exogenous driving mechanisms to explore innovation pathways within the framework of flow-space restructuring. Recent findings also suggest a significant positive spatial correlation between regional public health development and the efficiency of collaborative medical innovation, underscoring the importance of understanding spatial linkages in industry-specific innovation networks (58).
Given this context, this study examines the innovation network of the advanced medical equipment and device manufacturing industry and analyses the structural characteristics of the regional innovation network in the YRD from both National-Regional Perspectives. This approach facilitates the identification of innovation development patterns in the industry, promotes the optimal allocation of resources, and accelerates the localization of advanced medical equipment and devices in preparation for potential public health crises. Additionally, it provides theoretical foundations and practical references for national policy formulation and coordinated innovation development in the YRD. This study is important in two key ways. First, this study leverages nearly two decades of phased data and employs social network analysis to address the limitations of traditional regional economic studies in dynamic network topology analysis, thereby enriching the theoretical framework of the evolution of innovation networks. Second, through the construction of a dual-perspective (“national-regional”) analytical framework and comparative analysis of cross-scale innovation network indicators, this study uncovers the integration and flow characteristics of innovation elements at different spatial scales. This approach surpasses the limitations of single-scale research, offers a novel stratified paradigm for studying industrial innovation networks, and provides practical insights for optimizing innovation-based responses during health emergencies, enhancing urban resilience against future shocks.
2 Research data and methods
2.1 Research subjects and data
Based on the classification codes of strategic emerging industries combined with the national economic industry codes, patents related to the advanced medical equipment and device manufacturing industry over the past two decades (2005–2024) were retrieved from the Incopat Global Patent Database. Only patents with at least two applicants in the patent ownership claims were considered, resulting in a total of 35,094 relevant patents. When patent collaborations were calculated, if a joint application for a patent was made by applicants A, B, and C, collaborations were counted as one instance each for AB, AC, and so forth. Data retrieval was conducted on February 10, 2025.
To objectively capture the evolutionary characteristics of the innovation network in the advanced medical equipment and device manufacturing industry, a time-segmented research approach was adopted. The study period was divided into four time intervals: 2005–2009, 2010–2014, 2015–2019, and 2020–2024.
2.2 Research methods
2.2.1 Social network analysis (SNA)
This study applies social network analysis (SNA) to examine the structural characteristics of innovation collaboration networks in the advanced medical equipment and device manufacturing industry. Based on joint patent data from 2005 to 2024, innovation networks are constructed where nodes represent firms, universities, or research institutions, and edges represent co-application relationships. The networks are directed and weighted, with edge weights corresponding to the number of joint patent applications. Key metrics such as network density, modularity, degree centrality, average path length, and clustering coefficient are used to assess the scale, clustering, and actor roles in the network. National and Yangtze River Delta (YRD) regional networks are analyzed separately to capture both macro and localized collaboration dynamics. This method helps reveal the evolution and spatial heterogeneity of innovation linkages in a strategically significant industry (59–64).
2.2.2 Geodetector analysis
The factor detection module of the geodetector method was used to analyze the relationship among the weighted centrality of the innovation network and influencing factors such as urban economic development, technological innovation, the policy/social environment, and infrastructure from a National-Regional Perspective (65–68).
3 Evolution of the innovation network in the advanced medical equipment and device manufacturing industry from a national-regional perspective
3.1 Structural characteristics of the innovation network in the YRD from a national perspective
The number of participating cities and network edges in the innovation network increased from 72 and 129 in Phase I to 271 and 2,073 in Phase IV (Table 1), respectively. However, the overall network density remained low, indicating that from a national perspective, there is still considerable room for collaborative innovation within the YRD’s advanced medical equipment and device manufacturing industry. The network modularity index initially increased and then decreased; the average clustering coefficient increased continuously, and the average path length decreased continuously. These patterns suggest that regional network connections have become more tightly knit and that the community structure has become increasingly complex.
The modularity index reflects the tightness of the network’s community structure. Innovation in advanced medical equipment and devices requires interdisciplinary collaboration across fields such as biomedical engineering and materials science, leading to cross-domain and cross-community characteristics in collaborative networks. Consequently, the modularity index remained relatively high. However, the pilot implementation of the Medical Device Marketing Authorization Holder system in the YRD in 2017 partially weakened the community boundaries defined by institutional types (e.g., Industry-university collaborations), leading to a temporary decline in the modularity index.
From a national perspective, the spatial differentiation of the weighted degree in the overall innovation network of the YRD’s advanced medical equipment and device manufacturing industry is significant. Over the past 20 years, the coefficient of variation for city centrality and weighted centrality in the network has increased from 2.4237 and 1.6177 in the first phase to 3.1924 and 1.7263 in the fourth phase, respectively, indicating that the spatial differentiation of weighted centrality has become more pronounced and that the polarization trend in network connection strength has intensified. Within the YRD, cities such as Shanghai, Suzhou, Nanjing, and Hangzhou, as well as cities outside the region, including Beijing, Shenzhen, and Guangzhou, have become increasingly important in the network. The proportion of cities where the average degree is greater than the average centrality decreased from 20.08% in Phase I to 16.24% in the fourth stage, indicating an increase in network polarization and an increase in the control power of core cities. This suggests a widening gap in innovation levels within the advanced medical equipment and device manufacturing industry for cities in the YRD.
Using the natural breaks method in ArcGIS, the cooperative innovation intensity in the fourth phase was classified into five levels and applied to other stages (Figure 1). The intensity and number of innovation collaborations between cities gradually increased. The number of cities in the first and second levels was relatively small, and these levels emerged only in the third and fourth stages. And a very clear distribution of lines is characterized by the fact that the lines are mainly concentrated in the eastern, central, and southern regions, especially the more coastal, the denser the lines. The hierarchical structure of the network changed significantly and formed a spatial pattern with Beijing and Shanghai at the core, radiating nationwide. The cooperation intensity among cities within the YRD and neighboring cities was greater than that among cities in other regions of the country. In Phases I and II, there were no cooperative innovation pairs at the first and second levels. In the third stage, there were no first-level cooperative innovation pairs, and the only second-level pairs were Beijing–Shanghai (192) and Shanghai–Suzhou (106). The third-level pairs included Beijing–Shenzhen, Nanjing–Suzhou, and 18 other pairs. In the fourth stage, there were four first-level cooperative innovation pairs: Shanghai–Suzhou (320), Beijing–Tianjin (312), Nanjing–Zhenjiang (245), and Beijing–Shanghai (235). The second level included 10 pairs, such as Beijing–Shenzhen, Beijing–Suzhou, and Shenzhen–Wuhan. The third level consisted of 34 pairs, including Beijing–Chengdu, Ningbo–Shanghai, and Beijing–Jinan.
The analysis of the top 10 cities in terms of centrality and net inflow within the YRD’s overall innovation network for the advanced medical equipment and device manufacturing industry from a national perspective shows several trends (Appendix Table 1). Within the YRD’s city, Shanghai consistently ranked second in centrality after Beijing, but its net inflow remained negative throughout all phases. Nanjing, Suzhou, and Hangzhou experienced significant increases in net inflow during Phases III and IV. Notably, Nanjing and Hangzhou transitioned from negative net inflow in Phases I and II to positive net inflow in Phases III and IV. This suggests that the two cities are gradually shifting from being exporters to importers of innovation resources and can attract more external innovation resources. The average net inflow remained negative from Phases I to III but became positive in Phase IV with an increasing standard deviation. This trend suggests a significant increase in regional collaboration within the YRD’s innovation network. The network evolved into a structure where Shanghai serves as a supercore city that drives and radiates innovation cooperation across surrounding cities, with highly active collaboration among internal cities.
The dominance of Shanghai can be attributed to its strong research foundation supported by top universities such as Fudan University and Shanghai Jiao Tong University, both of which are in the top 1% of the world in medical-related disciplines according to ESI, coupled with the clinical translation capabilities of institutions such as Shanghai Shende Wuchuang Era Medical Technology and Shanghai Changzheng Hospital. According to the “China Scientific and Technological Achievement Transformation 2024 Annual Report,” Shanghai ranks first in the amount of contracts for transferring, licensing, and investing in the local transformation of universities and institutes (69). These factors have established Shanghai as a core hub for collaborative innovation among industry, university, and research.
Outside the YRD, the influence of cities in the innovation cooperation network is relatively dispersed. Beijing has consistently ranked first in centrality and maintained a substantial lead over other cities, and its net inflow has increased continuously. This dominance is due primarily to Beijing’s strong foundation in basic research, which is supported by leading universities such as Peking University and Tsinghua University, in addition to the industrialization capabilities of companies such as Beijing Natong Medical Technology. Additionally, Beijing benefits from top-tier clinical validation resources provided by institutions such as the Chinese Academy of Medical Sciences’ Peking Union Medical College Hospital and the People’s Liberation Army General Hospital. These factors have fostered a triadic “university-enterprise-hospital” innovation ecosystem. Furthermore, Guangzhou and Shenzhen experienced significant increases in centrality by Phase IV, reaching 141 and 152, respectively, which indicates an expansion in the breadth of innovation cooperation. However, they still lagged behind Beijing, which had a centrality of 224.
Among the cities in central and western China, Chengdu and Wuhan exhibited large fluctuations in net inflow, highlighting the relative independence of most non-YRD cities in the national innovation network. Xi’an and Hefei were only in the top 10 in the first phase and were subsequently overtaken by cities in other geographies. Of the remaining Midwestern cities, only Zhengzhou tied with Qingdao in the second phase. Beijing’s leading role in innovation cooperation continues to strengthen, competition between Guangzhou and Shenzhen remains intense, and cities in central and western China display insufficient stability in innovation collaboration.
For the types of industry-university-research collaboration between the YRD and the rest of the country (Table 2), industry–industry collaboration has shown continuous growth, rising from 13.33% in Phase I to 53.87% in Phase IV and maintaining the leading position since Phase II. Industry–research collaboration peaked at 28.95% in Phase II but gradually declined from Phase III onwards, reaching only 23.42% in Phase IV. Moreover, industry-university collaboration, research-research collaboration, and university-research collaboration have continuously declined, whereas university-university collaboration has fluctuated, with the type of collaboration with the lowest share.

Table 2. Types of industry-university-research collaboration in the innovation network from a national perspective.
Overall, driven by the market demand in the advanced medical equipment and device manufacturing industry, the need for collaborative innovation among enterprises has surged, which has increased the dominance of industry–industry collaboration. This type of collaboration plays a significant role in innovation cooperation between the YRD and the rest of the country. In contrast, knowledge-intensive collaborations such as industry-university and industry-research partnerships have gradually declined. The collaboration between the YRD and the rest of the country tends to be oriented toward short-term benefits, with research–research collaboration experiencing the most rapid decline. This situation highlights the need for improved coordination in basic research.
3.2 Structural characteristics of the innovation network in the YRD from a local perspective
Figure 2 shows that, from a local perspective, the intensity of collaborative innovation among cities within the YRD in the advanced medical equipment and device manufacturing industry has grown continuously, with increasingly close connections. Consistent with the national trend, the second level occurs in Phase III and the first level in Phase IV, and shows a radiation from the core city to other cities. Moreover, the first and second levels are mostly found among close neighboring cities, and the lower levels can radiate farther away. The number of collaborating cities and network edges increased from 19 cities and 25 edges in Phase I to 40 cities (excluding Huangshan) and 248 edges in Phase IV, covering nearly all cities within the YRD (Table 3). The increasing network density and average clustering coefficient indicate tighter network connections, whereas the declining network modularity index suggests an increase in cross-community collaborative innovation within the network. This trend also reflects a weakening of administrative segmentation between provinces in the region. In contrast, administrative boundaries between provinces are more clearly defined from the national perspective.

Figure 2. Characteristics of the innovation network structure within the YRD region from a local perspective over the past 20 years.
From a local perspective, the spatial differentiation of weighted degree centrality among cities in the YRD innovation network for the advanced medical equipment and device manufacturing industry is evident. Over the past 20 years, the coefficient of variation for city centrality in the network decreased from 1.0477 in Phase I to 0.9417 in Phase IV, whereas the coefficient of variation for weighted city centrality increased from 1.2007 in Phase I to 1.8240 in Phase IV. This indicates that differences in the breadth of connections among YRD cities have diminished, with peripheral cities increasing their participation in the innovation network. However, disparities in the intensity of collaborative innovation among cities have widened to form a distinct core-periphery structure. The spatial pattern of the YRD innovation network is characterized by Shanghai as the core with Suzhou, Nanjing, Zhenjiang, and Hangzhou as secondary cores, while other cities remain on the periphery.
Using the natural breaks classification method in ArcGIS, the collaborative innovation intensity in Phase IV was divided into five levels and applied to the previous phases. The results show that in Phases I and II, no collaborative innovation pairs were classified at the first or second level. In Phase III, no pairs were at the first level, and only one pair—Shanghai–Suzhou—fell into the second level, with an innovation intensity of 106. In Phase IV, two pairs reached the first level, with Shanghai–Suzhou advancing from the second to the first level and Zhenjiang–Nanjing newly entering the first level. Moreover, three pairs—Suzhou–Zhenjiang, Jiaxing–Shanghai, and Nantong–Shanghai—were classified at the second level.
Overall, collaborative innovation was relatively sparse in the early phases, but by Phases III and IV, network connections had become denser. However, high-level collaborative innovation remained concentrated in the eastern part of the YRD and occurred primarily in core cities such as Shanghai, Suzhou, Nanjing, and Zhenjiang. Furthermore, high-level innovation collaboration was mostly interprovincial; cross-provincial innovation cooperation gradually increased, indicating a weakening of administrative segmentation between provinces.
By analyzing the top 10 cities in terms of centrality and their net inflow degree within the YRD innovation network for the advanced medical equipment and device manufacturing industry from a local perspective (Appendix Table 2), it becomes evident that as the innovation network has continued to develop, Shanghai has gradually become the sole innovation leader in the region, whereas Nanjing has emerged as a key city for innovation collaboration. Hefei is the city with the largest change in centrality, dropping out of the top 10 in the next phase, from sixth in Phase I. The number of cities with a negative net inflow degree decreased from six in Phase I to just one in Phase IV. By Phase IV, only Shanghai had a negative net inflow degree that continued to decline, whereas all other cities had positive values. This trend shows that these YRD cities have absorbed more innovation resources from regional networks than exported, while Shanghai has continued to channel resources to its neighbors, playing the role of a core hub.
Shanghai consistently ranked first in centrality. Its net inflow degree dropped from −15 to −138, reflecting its absolute dominance as the central hub within the innovation network. Nanjing’s rise was particularly notable: its centrality increased from 7 to 42, and its net inflow degree surged from −3 to 240. Since Phase III, Nanjing has become a major innovation collaboration city within the YRD, likely due to its abundant higher education resources and strong local policy support.
Additionally, mid-sized cities such as Nantong and Jiaxing have experienced rapid growth and have gradually transitioned from peripheral cities to secondary core cities. These cities serve as crucial supplements to the collaborative innovation network. Overall, the YRD network exhibits a trend of multicentre coordination and dynamic evolution and forms a three-tiered structure with Shanghai as the core, secondary hubs that provide support, and midsized cities that serve as supplementary nodes.
From a local perspective, with regard to the types of industry-university-research collaboration among cities within the YRD (Table 4), industry–industry collaboration has continuously increased; it rose from 44.23% in Phase I to 66.86% in Phase IV and maintained its leading position throughout. Although industry-university collaboration peaked at 26.96% in Phase II, it declined to 10.82% in Phase IV. Industry–research collaboration and research–research collaboration have fluctuated within the YRD, whereas university–university and university–research collaboration have declined significantly.

Table 4. Types of industry-university-research collaboration in the innovation network from a local perspective.
Compared to the national level, both industry–industry and industry-university collaboration within the YRD increased slightly. The strong demand for collaborative innovation among enterprises highlights the vitality of industry partnerships, and the development of university alliances has yielded positive results. However, university–industry collaboration and university-university collaboration lack a long-term incentive mechanism. In the field of research coordination, while industry-research and research-research collaborations in the YRD demonstrate some resilience compared with the national level, knowledge flow remains weak, possibly due to institutional and systemic barriers.
4 Analysis of network influencing factors
4.1 Selection of influencing factors
Research on the factors that influence collaborative innovation suggests that a city’s economic development, technological capabilities, infrastructure, and policies significantly affect its participation in collaborative innovation networks (33–42). On the basis of these insights and in line with the principles of comprehensiveness and data availability, the weighted degree centrality of cities in the advanced medical equipment and device manufacturing industry innovation network during the fourth phase is selected as the dependent variable. The independent variables include factors that represent economic development (economic development level, financial support, market activity, industrial economic scale, trade openness, and economic modernization level), technological innovation (technological commercialization capacity, innovation output, and the density of core innovation entities in cities), policy/social factors (talent cultivation support, scientific and technological innovation support, and development zone policies), and infrastructure (telecommunications infrastructure and medical resource levels).
For higher education institutions, double first-class universities are assigned a value of 2, whereas regular higher education institutions are assigned a value of 1. Similarly, for development zones, national-level development zones are assigned a value of 2, whereas provincial-level development zones are assigned a value of 1 to reflect the differences in institutional support, resource allocation, and policy strength between zones of different administrative levels (63). Before geographical detection analysis is conducted, ArcGIS is used to classify the data into five levels using the natural breaks method. The data for the influencing factors were sourced from the China Urban Statistical Yearbook and relevant provincial statistical yearbooks.
4.2 Analysis of influencing factor results
The results of the geographical detector analysis (Appendix Table 3) indicate that economic development, technological innovation, policy/social dimensions, and infrastructure all significantly impact the innovation network of the advanced medical equipment and device manufacturing industry from both the national and local perspectives. Factors with a correlation coefficient above 0.8 are classified as core influencing factors.
From a national perspective, financial support, trade openness, technological innovation output, and scientific and technological innovation support are identified as core influencing factors. From a local perspective, financial support, market activity, and telecommunications infrastructure are the core influencing factors.
Economic development is the core driving force of the innovation network of the advanced medical equipment and device manufacturing industry. The economic development level, industrial economic scale, and economic modernization all have significant effects. Financial support exceeds 0.8 from both national and local perspectives, highlighting the critical role of financial institutions in supporting the innovation network. This underscores the strong support provided by capital mobility to industry innovation. Market activity is more influential locally than at the national level, suggesting that consumer demand within the YRD region plays a more prominent role in shaping the innovation network. Additionally, trade openness exhibits a significant disparity between national and local perspectives, with the national level showing a stronger driving force for industrial innovation. This may be due to the varying degrees of export-oriented economic structures within the YRD, which leads to a more dispersed influence at the regional level.
Technological innovation serves as a crucial engine for the innovation networks of the advanced medical equipment and device manufacturing industry. Technological innovation output is a core factor at the national level, which reflects the importance of technology reserves. A vibrant technology transaction market accelerates the flow of innovation elements. Locally, the technological commercialization capability is close to the core threshold, indicating that the YRD relies on an active technology transaction market to drive innovation. However, the overall density of core innovation entities in cities remains low, particularly in the YRD. This may be due to the uneven distribution of high-tech enterprises (e.g., Hangzhou and Suzhou have over 15,000 national-level high-tech enterprises, whereas Zhoushan, Huainan, and Chizhou have only a few hundred), which restricts regional collaboration.
Policy and social factors provide critical support for the innovation network. Scientific and technological innovation support is the only core factor at the national level, which demonstrates the direct impact of government funding on the innovation network. Locally, development zone policies and university resources are close to the core threshold, indicating that the YRD relies on industrial parks and university intellectual resources to drive innovation. Higher education expenditures help to cultivate high-tech innovation talent, which provides research and development personnel for innovative enterprises and enhances their competitive advantage.
Infrastructure serves as the foundational guarantee for the innovation network. Telecommunications infrastructure and medical resources are essential aspects as they attract high-end talent and reduce innovation costs.
5 Conclusions and implications
5.1 Conclusion
Based on patent data from 2005 to 2014, this study analyses the spatial structure and influencing factors of the innovation network for the advanced medical equipment and device manufacturing industry in the YRD from both national and local perspectives. The following conclusions are drawn.
1. Network structure characteristics: At the national level, the innovation network exhibits a polarization pattern that features a strong core and a weak periphery, whereas the YRD forms a multilevel collaborative network with reduced administrative segmentation between provinces.
2. Imbalance in industry-university-research collaboration: Industry collaboration dominates the innovation network, but knowledge-intensive cooperation continues to weaken, and basic research collaboration remains insufficient. This imbalance of integration limits the industry’s ability to generate and disseminate critical innovations quickly during emergencies.
3. Significant regional disparities: Core cities within the YRD exhibit a high concentration of innovation resources, whereas central and peripheral cities face challenges in maintaining stability, leading to a widening innovation gap. However, mid-sized cities such as Nantong and Jiaxing are gradually evolving into secondary innovation hubs.
4. Influence factors: Economic development is the core driving force of the innovation network, technological innovation serves as a crucial engine, policy/social dimensions provide essential support, and infrastructure forms the fundamental guarantee. These factors provide concrete directional advice to policymakers on enhancing public health resilience in the context of crisis prevention.
5.2 Implications and recommendations
1. Based on the analysis of influencing factors, government financial support is found to have a direct impact on regional innovation performance. To further strengthen mechanisms for collaborative innovation, policy instruments such as tax incentives and refined benefit-sharing arrangements could be introduced to promote the sustainable development of regional public health industries, especially for medium-sized regional centers (e.g., Nantong, Jiaxing). Technology spillover from core cities such as Beijing and Shanghai should be encouraged, cross-regional coordination should be enhanced, and administrative barriers should be reduced to increase participation from cities in central and western regions.
2. Both nationally and in the YRD, collaboration between universities and research institutions remains limited, particularly in the field of fundamental research. To address this gap, the research evaluation system should be improved by establishing dedicated funding for foundational research activities in emerging innovation regions. In mature academic clusters (e.g., Shanghai, Nanjing, Hangzhou), dual-employment programs between universities and enterprises, as well as joint industry–university–research, could be promoted to increase the depth and frequency of knowledge-intensive collaborations, such as university–university, university–research, and research–research partnerships. These will foster deeper and broader innovation collaborations, improving the capacity to address future challenges.
3. Given that active technology markets play a crucial role in accelerating the flow of innovation resources, it is necessary to promote patent commercialization through well-developed transfer platforms and efficient transaction services in developed innovation centers. Cultivating sub-innovation hubs is conducive to enhancing the robustness of the overall network, which requires strengthening the transformation of scientific and technological achievements, reinforcing the development of supporting infrastructure, and increasing investment in key innovation drivers.
5.3 Theoretical contributions
1. This study employs social network analysis to examine the evolving structure of innovation networks and addresses a gap in traditional regional economic research, which often lacks dynamic analysis of network topology. This study contributes to the theoretical framework of the evolution of innovation networks (11–37).
2. By comparing innovation network indicators across different spatial scales, this study reveals how innovation factors integrate and flow at varying levels, which overcomes the limitations of single-scale research. This study introduces a new multilayered approach to research on industrial innovation networks (37–46).
3. This study expands the understanding of the medical device and manufacturing industry and enriches the understanding of industrial organization and industry chain aspects through the perspective of innovation and cooperation, and provides a network location and technology upgrading difficulty embedded perspective to the theory of industrial technology upgrading (2, 5, 48–57).
5.4 Limitations and future research directions
1. This study focuses solely on the YRD. Future research could compare findings with other regions, such as the Pearl River Delta and Beijing-Tianjin-Hebei, to extract more universally applicable patterns of the evolution of regional industrial innovation.
2. This study relies on patent collaboration data to analyze the advanced medical equipment and device manufacturing industry. Future studies could integrate multi-source data, e.g., academic collaboration, researcher mobility, project partnerships, and project funding relationships, to provide a more comprehensive and multi-layered understanding of the industry’s innovation landscape.
3. The analysis of influencing factors is based on macroeconomic data and lacks insights into the micro-level behaviors of innovation actors such as enterprises and universities. Future research could employ interviews or textual analysis of collaborative patents and academic papers to explore the underlying mechanisms of innovation networks.
4. The discussion of the global–local paradigm in this study remains largely theoretical. Future research could develop quantitative models by incorporating cross-national patent collaboration data to further explore the intensity and pathways of multiscale innovation factor flows.
Data availability statement
The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding authors.
Author contributions
FH: Methodology, Conceptualization, Funding acquisition, Writing – original draft, Writing – review & editing. HY: Data curation, Methodology, Writing – review & editing. LQ: Visualization, Writing – review & editing, Software. WX: Formal analysis, Writing – review & editing. ZR: Resources, Writing – review & editing. SW: Writing – review & editing, Investigation. HZ: Conceptualization, Methodology, Writing – review & editing. YC: Project administration, Writing – review & editing. HH: Supervision, Writing – review & editing.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the National Natural Science Foundation of China (Grant No. 72373135) and the Humanities and Social Sciences Research Fund of the Ministry of Education of China (Grant No. 22YJAZH027).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Gen AI was used in the creation of this manuscript.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fpubh.2025.1635475/full#supplementary-material
Footnotes
1. ^National Medical Products Administration Southern Medicine Economic Research Institute: 2024 China Medical Device Industry Development Report, published in November 2024. Available on the official website of the Shanghai Municipal Commission of Economy and Informatization (https://www.sheitc.sh.gov.cn/gydt/20241230/b070b36f40104e2baf8b3caff5e42153.html) [Accessed: March 5, 2025].
2. ^Roland Berger: Current Situation and Trends in China’s Medical Device Industry, initially published in February 2023 and updated in March 2024 (with supplementary data). Available on the Roland Berger official website (https://www.sgpjbg.com/baogao/116111.html) [Accessed: March 5, 2025].
3. ^National Medical Products Administration Southern Medicine Economic Research Institute & NMPA Medical Device Technology Review and Inspection YRD Subcentre: YRD Medical Device Industry Development Research Report, jointly published in November 2024. Available at (https://finance.sina.com.cn/money/smjj/2024-11-19/doc-incxhkcn8227431.shtml) [Accessed: March 5, 2025].
References
1. Hu, H, Wang, XP, Zhou, HY, Jin, Z, and Wei, SB. Global trade pattern of medical devices and China's trade position: based on data from 2001 to 2020. Front Public Health. (2022) 10:926216. doi: 10.3389/fpubh.2022.926216
2. Lee, M. Strategies for promoting the medical instrument industry in Korea: an analytical hierarchy process analysis. Int J Environ Res Public Health. (2018) 15:1–13. doi: 10.3390/ijerph15122659
3. Ng, I, Parry, G, Wild, P, McFarlane, D, and Tasker, P. Complex engineering service systems: concepts and research. 1st ed. London, UK: Springer-Verlag London Limited (2014).
4. MacLaren, G, Fisher, D, and Brodie, D. Preparing for the most critically ill patients with COVID-19: the potential role of extra-corporeal membrane oxygenation. JAMA. (2020) 323:1245. doi: 10.1001/jama.2020.2342
5. Li, JT, Han, DZ, Wu, ZD, Wang, JX, Li, KC, and Castiglione, A. A novel system for medical equipment supply chain traceability based on alliance chain and attribute and role access control. Futur Gener Comput Syst. (2023) 142:195–211. doi: 10.1016/j.future.2022.12.037
6. Florida, R, Adler, P, and Mellander, C. The city as innovation machine. Reg Stud. (2017) 51:86–96. doi: 10.4324/9781315143736-8
7. Simmie, J. Innovation and urban regions as national and international nodes for the transfer and sharing of knowledge. Reg Stud. (2003) 37:607–20. doi: 10.1080/0034340032000108714
8. Kalliomäki, H, Oinas, P, and Salo, T. Innovation districts as strategic urban projects: the emergence of strategic spatial planning for urban innovation. Eur Plan Stud. (2024) 32:78–96. doi: 10.1080/09654313.2023.2216727
9. Feng, ZJ, Cai, HC, and Zhou, W. Structural characteristics and spatial patterns of the technology transfer network in the Guangdong-Hong Kong-Macao Greater Bay Area. Sustain For. (2020) 12:2204. doi: 10.3390/su12062204
10. Zhang, C, Liu, BL, and Yang, YH. Digital economy and urban innovation level: a quasi-natural experiment from the strategy of “digital China”. Hum Soc Sci Commun. (2024) 11:1–12. doi: 10.1057/s41599-024-03122-1
11. Li, YC, and Phelps, NA. Megalopolitan glocalization: the evolving relational economic geography of intercity knowledge linkages within and beyond China's Yangtze River Delta region, 2004-2014. Urban Geogr. (2019) 40:1310–34. doi: 10.1080/02723638.2019.1585140
12. Li, YC, and Phelps, NA. Knowledge polycentricity and the evolving Yangtze River Delta megalopolis. Reg Stud. (2017) 51:1035–47. doi: 10.1080/00343404.2016.1240868
13. Maggioni, M, Nosvelli, M, and Uberti, TE. Space versus networks in the geography of innovation: a European analysis. Pap Reg Sci. (2007) 86:471–93. doi: 10.1111/j.1435-5957.2007.00130.x
14. Yao, L, Li, J, and Li, J. Urban innovation and intercity patent collaboration: a network analysis of China’s national innovation system. Technol Forecast Soc Change. (2020) 160:120185. doi: 10.1016/j.techfore.2020.120185
15. Hu, F, Wei, SB, Qiu, LP, Hu, H, and Zhou, HY. Innovative association network of new energy vehicle charging stations in China: structural evolution and policy implications. Heliyon. (2024) 10:e24764. doi: 10.1016/j.heliyon.2024.e24764
16. Chesbrough, HW. Open innovation: the new imperative for creating and profiting from technology. 1st ed. Boston, USA: Harvard Business School Press (2003).
17. Gereffi, G, Humphrey, J, and Sturgeon, T. The governance of global value chains. Rev Int Polit Econ. (2005) 12:78–104. doi: 10.1080/09692290500049805
18. Giuliani, E, and Bell, M. The micro-determinants of meso-level learning and innovation: evidence from a Chilean wine cluster. Res Policy. (2005) 34:47–68. doi: 10.1016/j.respol.2004.10.008
19. Yan, MR, Yan, HY, Chen, YR, Zhang, YK, Yan, XR, and Zhan, YX. Integrated green supply chain system development with digital transformation. Int J Log Res Appl. (2025):1–22. doi: 10.1080/13675567.2025.2492217
20. Schilling, M, and Phelps, C. Interfirm collaboration networks: the impact of large-scale network structure on firm innovation. Manag Sci. (2007) 53:1113–26. doi: 10.1287/mnsc.1060.0624
21. Giuliani, E. The selective nature of knowledge networks in clusters: evidence from the wine industry. Soc Sci Electron Publ. (2007) 7:139–68. doi: 10.1093/jeg/lbl014
22. Najafi-Tavani, S, Najafi-Tavani, Z, Naudé, P, Oghazi, P, and Zeynaloo, E. How collaborative innovation networks affect new product performance: product innovation capability, process innovation capability, and absorptive capacity. Ind Mark Manag. (2018) 73:193–205. doi: 10.1016/j.indmarman.2018.02.009
24. Cantner, U, and Graf, H. The network of innovators in Jena: an application of social network analysis. Res Policy. (2006) 35:463–80. doi: 10.1016/j.respol.2006.01.002
25. Graf, H. Gatekeepers in regional networks of innovators. Camb J Econ. (2011) 35:173–98. doi: 10.1093/cje/beq001
26. Cooke, P. Qualitative analysis and comparison of firm and system incumbents in the new ICT global innovation network. Eur Plan Stud. (2013) 21:1323–40. doi: 10.1080/09654313.2012.755828
27. Steinmo, M, and Rasmussen, E. How firms collaborate with public research organizations: the evolution of proximity dimensions in successful innovation projects. J Bus Res. (2016) 69:1250–9. doi: 10.1016/j.jbusres.2015.09.006
28. Wanzenböck, I, Scherngell, T, and Lata, R. Embeddedness of European regions in European Union-funded Research and Development (R&D) networks: a spatial econometric perspective. Reg Stud. (2015) 49:1685–705. doi: 10.1080/00343404.2013.873119
29. Andersson, DE, Gunessee, S, Matthiessen, CW, and Find, S. The geography of Chinese science. Environ Plan A. (2014) 46:2950–71. doi: 10.1068/a130283p
30. Shi, S, Wong, SK, and Zheng, C. Network capital and urban development: an inter-urban capital flow network analysis. Reg Stud. (2022) 56:406–19. doi: 10.1080/00343404.2021.1955098
31. Awate, S, and Mudambi, R. On the geography of emerging industry technological networks: the breadth and depth of patented innovations. J Econ Geogr. (2018) 18:391–419. doi: 10.1093/jeg/lbx032
32. Balland, PA, Belso-Martínez, JA, and Morrison, A. The dynamics of technical and business knowledge networks in industrial clusters: embeddedness, status, or proximity? Econ Geogr. (2016) 92:35–60. doi: 10.1080/00130095.2015.1094370
33. Hu, F, Qiu, LP, Wei, SB, Zhou, HY, Bathuure, IA, and Hu, H. The spatiotemporal evolution of global innovation networks and the changing position of China: a social network analysis based on cooperative patents. R&D Manag. (2024) 54:574–89. doi: 10.1111/radm.12662
34. Yang, XM, Qu, S, and Kong, LK. The impact of cooperation network evolution on communication technology innovation: a network interaction perspective. Systems. (2025) 13:126. doi: 10.3390/systems13020126
35. Wang, FL, Su, Q, and Zhang, ZM. The influence of collaborative innovation network characteristics on firm innovation performance from the perspective of innovation ecosystem. Kybernetes. (2024) 53:1281–305. doi: 10.1108/K-04-2022-0553
36. Zhang, H, Jiang, LL, Zhou, J, Chu, NC, and Li, FJ. The characteristics and influencing factors of spatial network of city-based innovation correlation in China: from the perspective of high tech zones. Sci Rep. (2023) 13:16289. doi: 10.1038/s41598-023-43402-5
37. Feng, ZJ, Cai, HC, Chen, Z, and Zhou, W. Influence of an interurban innovation network on the innovation capacity of China: a multiplex network perspective. Technol Forecast Soc Change. (2022) 180:121651. doi: 10.1016/j.techfore.2022.121651
38. Zhang, RX, Tang, YY, Zhang, YX, and Wang, ZY. Collaborative relationship discovery in green building technology innovation: evidence from patents in China's construction industry. J Clean Prod. (2023) 391:136041. doi: 10.1016/j.jclepro.2023.136041
39. Zhang, ZH, and Rao, W. Key risks and development strategies for China’s high-end medical equipment innovations. Risk Manag Healthc Policy. (2021) 14:3037–56. doi: 10.2147/RMHP.S306907
40. Lai, HB, Shi, H, and Zhou, Y. Regional technology gap and innovation efficiency trap in Chinese pharmaceutical manufacturing industry. PLoS One. (2020) 15:e0233093. doi: 10.1371/journal.pone.0233093
41. Ureña, JM, Menerault, P, and Garmendia, M. The high-speed rail challenge for big intermediate cities: a national, regional and local perspective. Cities. (2009) 26:266–79. doi: 10.1016/j.cities.2009.07.001
42. Ouyang, YR, Cai, YP, Xie, YL, Yue, WC, and Guo, HJ. Multi-scale simulation and dynamic coordination evaluation of water-energy-food and economy for the Pearl River Delta City cluster in China. Ecol Indic. (2021) 130:108155. doi: 10.1016/j.ecolind.2021.108155
43. Yang, TT, Ruan, WQ, Zhang, SN, and Li, YQ. The influence of the COVID-19 pandemic on tourism demand for destinations: an analysis of spatial heterogeneity from a multi-scale perspective. Asia Pac J Tour Res. (2021) 26:793–810. doi: 10.1080/10941665.2021.1919160
44. Chen, WX, and Chi, GQ. Urbanization and ecosystem services: the multi-scale spatial spillover effects and spatial variations. Land Use Policy. (2022) 114:105964. doi: 10.1016/j.landusepol.2021.105964
45. Rybnicek, R, and Königsgruber, R. What makes industry–university collaboration succeed? A systematic review of the literature. J Bus Econ. (2019) 89:221–50. doi: 10.1007/s11573-018-0916-6
46. Sheppard, E., and McMaster, R.B. Scale and geographic inquiry: nature, society, and method. Oxford, UK: Blackwell Publishing Ltd. (2004) 129–153.
47. Xie, J, Tian, JY, Hu, Y, Wang, Q, and Dai, ZQ. Imported intermediate goods, intellectual property protection, and innovation in Chinese manufacturing firms. Econ Model. (2025) 144:106960. doi: 10.1016/j.econmod.2024.106960
48. Qiu, LP, Yu, RJ, Hu, F, Zhou, HY, and Hu, H. How can China's medical manufacturing listed firms improve their technological innovation efficiency? An analysis based on a three-stage DEA model and corporate governance configurations. Technol Forecast Soc Change. (2023) 194:122684. doi: 10.1016/j.techfore.2023.122684
49. MacNeill, AJ, Hopf, H, Khanuja, A, Alizamir, S, Bilec, M, Eckelman, MJ, et al. Transforming the medical device industry: road map to a circular economy. Health Aff. (2020) 39:2088–97. doi: 10.1377/hlthaff.2020.01118
50. Jakovljevic, M, Wu, WQ, Wu, W, Merrick, J, Cerda, A, Varjacic, M, et al. Asian innovation in pharmaceutical and medical device industry–beyond tomorrow. J Med Econ. (2021) 24:42–50. doi: 10.1080/13696998.2021.2013675
51. Chatterji, AK, and Fabrizio, KR. Does the market for ideas influence the rate and direction of innovative activity? Evidence from the medical device industry. Strateg Manag J. (2016) 37:447–65. doi: 10.1002/smj.2340
52. Zhang, XS, Yang, L, Zhang, XH, and Xu, JC. Research on the development trend, evolution, and spatial local characteristics of the intelligent smart medical industry in the Yangtze River Economic Belt. Front Public Health. (2023) 10:1022547. doi: 10.3389/fpubh.2022.1022547
53. Nayeri, S, Sazvar, Z, and Heydari, J. A global-responsive supply chain considering sustainability and resiliency: application in the medical devices industry. Socio Econ Plan Sci. (2022) 82:101303. doi: 10.1016/j.seps.2022.101303
54. Lee, SS. A comparative analysis on the competitiveness of the Korea-China medical devices industry. (Master’s thesis) Konkuk University (2020).
55. Lee, Y, and Jeong, Y. The competitiveness study of Korea medical device industry in China. Int Commer Inf Rev. (2015) 17:93–114. doi: 10.15798/kaici.17.3.201509.93
56. Zhang, WF, and Chatwin, C. Trade competitiveness analysis of the Chinese medical device industry. Int J Trade Global Mark. (2023) 17:64–87. doi: 10.1504/IJTGM.2023.130105
57. Kim, DS. An analysis of the patent trend of Korean medical equipment manufacturers: 98 companies holding domestic registered patents through R&D. J Bus Econ. (2018) 34:165–87. doi: 10.22793/INDINN.2018.34.3.007
58. Chen, LX, Huang, JY, and Ge, XY. Dual circulation strategy, regional healthcare development, and medical collaborative innovation efficiency: evidence from Chinese cities. Front Public Health. (2024) 12:1371867. doi: 10.3389/fpubh.2024.1371867
59. He, FT, Ji, LY, and Li, CB. Grid disaster risk identification based on social network analysis. Reliab Eng Syst Saf. (2025) 256:110756. doi: 10.1016/j.ress.2024.110756
60. Tan, JJ, Wang, YM, and Chu, JF. A consensus method in social network large-scale group decision making with interval information. Expert Syst Appl. (2024) 237:121560. doi: 10.1016/j.eswa.2023.121560
61. Di, KX, Xu, RH, Liu, ZK, and Liu, RK. How do enterprises’ green collaborative innovation network locations affect their green total factor productivity? Empirical analysis based on social network analysis. J Clean Prod. (2024) 438:140766. doi: 10.1016/j.jclepro.2024.140766
62. Baziyad, H, Kayvanfar, V, and Toloo, M. A data envelopment analysis model for opinion leaders’ identification in social networks. Comput Ind Eng. (2024) 190:110010. doi: 10.1016/j.cie.2024.110010
63. Hu, F, Yang, HJ, Qiu, LP, Wei, SB, Hu, H, and Zhou, HY. Spatial structure and organization of the medical device industry urban network in China: evidence from specialized, refined, distinctive, and innovative firms. Front Public Health. (2025) 13:1518327. doi: 10.3389/fpubh.2025.1518327
64. Yang, HJ, Wei, SB, Zhou, HY, Hu, F, Chen, YF, and Hu, H. The global industrial robot trade network: evolution and China’s rising international competitiveness. Systems. (2025) 13:361. doi: 10.3390/systems13050361
65. Tao, HF, and Zhou, JF. Study on the geographic distribution and influencing factors of Dai settlements in Yunnan based on Geodetector. Sci Rep. (2024) 14:8948. doi: 10.1038/s41598-024-59449-x
66. Guo, YJ, Cheng, LR, Ding, AZ, Yuan, YM, Li, ZY, Hou, YZ, et al. Geodetector model-based quantitative analysis of vegetation change characteristics and driving forces: a case study in the Yongding River basin in China. Int J Appl Earth Obs Geoinf. (2024) 132:104027. doi: 10.1016/j.jag.2024.104027
67. Xiao, WB, Huang, E, Li, CC, and Li, HP. Investigating the spatial distribution and influencing factors of traditional villages in Qiandongnan based on ArcGIS and Geodetector. Sci Rep. (2025) 15:5786. doi: 10.1038/s41598-025-90179-w
68. Liu, T, Wang, MS, Wang, M, Xiong, Q, Jia, L, Ma, W, et al. Identification of the primary pollution sources and dominant influencing factors of soil heavy metals using a random forest model optimized by genetic algorithm coupled with geodetector. Ecotoxicol Environ Saf. (2025) 290:117731. doi: 10.1016/j.ecoenv.2025.117731
69. China Association for Science and Technology Evaluation and Achievement Management, Ministry of Science and Technology Science and Technology Evaluation Center, & China Institute of Science and Technology Information. Annual report on the transformation of science and technology achievements in China 2024 (higher education institutions and research institutes edition). Beijing, China: Science and Technology Literature Publishing House (2024).
Keywords: medical equipment, innovation network, spatial pattern, core cities, public health
Citation: Hu F, Yang H, Qiu L, Wang X, Ren Z, Wei S, Zhou H, Chen Y and Hu H (2025) Innovation networks in the advanced medical equipment industry: supporting regional digital health systems from a local–national perspective. Front. Public Health. 13:1635475. doi: 10.3389/fpubh.2025.1635475
Edited by:
Wei Wang, Chongqing Medical University, ChinaCopyright © 2025 Hu, Yang, Qiu, Wang, Ren, Wei, Zhou, Chen and Hu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Haiyan Zhou, emhvdWhhaXlhbnNoQGhvdG1haWwuY29t; Yufeng Chen, Y2hlbnl1ZmVuZ0BnbWFpbC5jb20=; Hao Hu, aHVoYW9obkBvdXRsb29rLmNvbQ==
†These authors have contributed equally to this work and share first authorship